Profilo
Paul A. Barsanti is Chief Technology Officer at IDEAYA Biosciences, Inc. since 2023.
Formerly, Dr. Barsanti was Head-Chemistry at Nurix Therapeutics, Inc. from 2014 to 2018.
Education includes an undergraduate degree conferred in 1993 and a doctorate conferred in 1996, both from the University of Bath.
Posizioni attive di Paul A. Barsanti
| Società | Posizione | Inizio |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 01/03/2023 |
Precedenti posizioni note di Paul A. Barsanti
| Società | Posizione | Fine |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2018 |
Formazione di Paul A. Barsanti
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
University of Bath
University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
















